Bulletin
Investor Alert

market pulse

March 16, 2010, 6:57 a.m. EDT · Recommend ·

Boston Scientific cut to sell by Goldman Sachs

Alert Email Print By Steve Goldstein

LONDON (MarketWatch) -- Boston Scientific /quotes/comstock/13*!bsx/quotes/nls/bsx (BSX 5.60, 0.00, 0.00%) was cut to conviction sell from neutral by Goldman Sachs on the company's announcement that it had stopped shipment and is retrieving inventory of all of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators in the U.S. Goldman said those devices accounted for about a fifth of the company's profit, and that the impact will not just be lost sales as brand loyalty from physicians will be impacted. St. Jude Medical [s stj] was taken off the conviction sell list but is still at sell, and Medtronic /quotes/comstock/13*!mdt/quotes/nls/mdt (MDT 36.97, +0.87, +2.41%) is still a neutral.

/quotes/comstock/13*!bsx/quotes/nls/bsx Boston Scientific Corp (BSX)
/marketstate/country/ The market is open5:36:34 am The market is closed5:36:34 am
$ 5.60
Change 0.00 0.00%
Volume 14.81m Real time quotes
/quotes/comstock/13*!mdt/quotes/nls/mdt Medtronic Inc (MDT)
/marketstate/country/ The market is open5:36:34 am The market is closed5:36:34 am
$ 36.97
Change +0.87 +2.41%
Volume 7.45m Real time quotes

Featured Stories

ALERT:

Link to MarketWatch's Slice.